| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/14/2002 | WO2001038491A3 Novel semaphorin domains |
| 03/14/2002 | WO2001036684A3 Mammalian toxicological response markers |
| 03/14/2002 | WO2001027634A3 Method for determining of autoantibodies against the tsh receptor |
| 03/14/2002 | WO2001027267A3 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 03/14/2002 | WO2001023572A3 Polynucleotides and polypeptides encoded thereby |
| 03/14/2002 | WO2001021651A3 Novel human protease inhibitor-like proteins and polynucleotides encoding the same |
| 03/14/2002 | WO2001020031A3 Polymorphisms in a klotho gene |
| 03/14/2002 | WO2001016364A3 Methods of diagnosing or prognosticating age-related macular degeneration |
| 03/14/2002 | WO2000066743A9 Viral expression vectors |
| 03/14/2002 | WO2000066608A9 Tumor necrosis factor-gamma |
| 03/14/2002 | WO2000065028A9 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 03/14/2002 | WO2000060083A9 Novel protein associated with cell stress response |
| 03/14/2002 | WO2000055353A9 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system |
| 03/14/2002 | WO2000055335A9 Pseudotyped lentiviral vectors and uses thereof |
| 03/14/2002 | WO2000053742A9 Polynucleotides and proteins encoded thereby |
| 03/14/2002 | WO2000052047A9 Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| 03/14/2002 | WO1997003998A9 Modulators of the function of fas receptors and other proteins |
| 03/14/2002 | US20020032918 Alteration of growth and adaptation under hypoxic conditions |
| 03/14/2002 | US20020032917 Scarecrow gene, promoter and uses thereof |
| 03/14/2002 | US20020032915 Detecting size defect in animal infants; obtain tissue biopsy, monitor expression of somatomedins in sample, amplified somatomedin concentration indicates potential size defect in animals |
| 03/14/2002 | US20020032323 Polynucleotide and polypeptide sequence information stored on computer readable media |
| 03/14/2002 | US20020032322 Nucleic acid molecule coding for a protein having a potassium permeable membrane, comprising more than one P domains and three, four, five or more than six transmembrane segments. |
| 03/14/2002 | US20020032321 Novel human transporter proteins and polynucleotides encoding the same |
| 03/14/2002 | US20020032314 Synthetic peptide neutrophil cell chemotactic agents |
| 03/14/2002 | US20020032313 Vascular endothelial cell growth factor antagonists |
| 03/14/2002 | US20020032312 Recombinant multispecific molecule comprising an anti-Fc receptor portion and an anti-target portion. |
| 03/14/2002 | US20020032311 Interleukin-19 |
| 03/14/2002 | US20020032310 Purified FRAG-1 specific antibody; nucleic acid comprising at least 15 contiguous nucleotides of a FRAG1 nucleic acid that hybridizes under stringent conditions to the FRAG1 nucleic acid. |
| 03/14/2002 | US20020032307 Hepadnavirus pre-S protein fragments |
| 03/14/2002 | US20020032306 Cyclopeptide derivatives |
| 03/14/2002 | US20020032162 For inducing immune responses in a vertebrate against Mycobacterial epitopes |
| 03/14/2002 | US20020032157 Methods of inhibiting ectopic calcification |
| 03/14/2002 | US20020032154 Interferon-suppressing placental lactogen peptides |
| 03/14/2002 | US20020032152 Anti-helicobacter vaccine complex |
| 03/14/2002 | US20020031832 Method of stable integration of DNA into neurons |
| 03/14/2002 | US20020031831 Plasmid for use in vaccination and gene therapy |
| 03/14/2002 | US20020031823 Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene |
| 03/14/2002 | US20020031818 Modification of Mdm2 activity |
| 03/14/2002 | US20020031810 Nucleotide sequences coding for the lipA gene |
| 03/14/2002 | US20020031806 Purified human erythropoietin receptor protein fragment and antibodies derived therefrom |
| 03/14/2002 | US20020031805 Polypeptide; for use in diagnosis and treatment of connective tissue defects |
| 03/14/2002 | US20020031804 Growth modulatory polypeptides, polynucleotides |
| 03/14/2002 | US20020031803 Expression system for production of therapeutic proteins |
| 03/14/2002 | US20020031802 Novel seven transmembrane proteins and polynucleotides encoding the same |
| 03/14/2002 | US20020031800 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | US20020031793 Assay for ykl-40 as a marker for degradation of mammalian connective tissue matrices |
| 03/14/2002 | US20020031785 Splice variants of brca1 and brca2 |
| 03/14/2002 | US20020031758 Aggregating preferential particles; obtain preferential particles, mix in solution, expose to charge, recover aggregates |
| 03/14/2002 | US20020031531 Immunotherapy for lung or urogenital cancer |
| 03/14/2002 | US20020031526 Reacting with a base to form a de-n-acetylated product, and depolymerizing with a nitrosation agent |
| 03/14/2002 | US20020031522 Modified CD40 receptor-associated factor 1(CRAFI) gene prevents cell activation |
| 03/14/2002 | US20020031520 Prevention and treatment of hepatocellular cancer |
| 03/14/2002 | US20020031510 Contacting B7-positive cell with first soluble ligand which recognizes and binds B7 antigen, and contacting gp39-positive cell with second soluble ligand which recognizes and binds gp39 antigen; inhibiting rejection of transplanted tissues |
| 03/14/2002 | US20020031499 Defective recombinant adenoviruses expressing cytokines for antitumor treatment |
| 03/14/2002 | US20020031496 Therapy for cellular accumulation in chronic inflammatory diseases |
| 03/14/2002 | US20020031493 Recombinant adenoviruses coding for glial-derived cell neurotrophic factor (gdnf) |
| 03/14/2002 | US20020031492 Providing a brain tumor sample, quantifying the expression of an interleukin-13 (IL-13) receptor in the sample; and correlating the quantity of expression of the IL-13 receptor with the tumor type or grade; prognosis |
| 03/14/2002 | US20020031491 Stem cell factor: composition claims |
| 03/14/2002 | US20020031473 In vivo chemosensitivity screen for human tumors |
| 03/14/2002 | DE10133427A1 Für das sigH-Gen kodierende Nukleotidsequenzen For the sigH gene coding nucleotide sequences |
| 03/14/2002 | DE10133426A1 Für das sigC-Gen kodierende Nukleotidsequenzen For the SIGC gene coding nucleotide sequences |
| 03/14/2002 | DE10126422A1 Für das sigE-Gen kodierende Nukleotidsequenzen For the sigE gene coding nucleotide sequences |
| 03/14/2002 | DE10109688A1 Neue für die Gene metR und metZ kodierende Nukleotidsequenzen New genes coding for the metric and Metz nucleotide sequences |
| 03/14/2002 | DE10108841A1 Neue für das citB-Gen kodierende Nukleotidsequenzen New coding for the citB gene nucleotide sequences |
| 03/14/2002 | DE10108463A1 Neue für das citA-Gen kodierende Nukleotidsequenzen New coding for the citA gene nucleotide sequences |
| 03/14/2002 | DE10044027A1 New nucleic acid encoding preprotein of mistletoe lectin, useful as diagnostic and therapeutic agents, also encodes polypeptide |
| 03/14/2002 | DE10043902A1 New nucleic acid for the barley homeobox gene JuBel2, useful for altering phenotype of plants, e.g. increased branching for improved crop yields |
| 03/14/2002 | DE10043331A1 New polynucleotide from coryneform bacteria, useful when overexpressed for increasing fermentative amino acid production, encodes sigma factor D |
| 03/14/2002 | DE10042742A1 Neue für das lipA-Gen kodierende Nukleotidsequenzen New coding for the lipA gene nucleotide sequences |
| 03/14/2002 | DE10042177A1 New acetylcholine receptor subunit, useful for identifying plant-protection and therapeutic agents, comprises segment of insect subunit inserted into vertebrate subunit |
| 03/14/2002 | DE10041541A1 New nucleic acid encoding moth allergens, related polypeptides and antibodies, useful in the diagnosis and treatment of arthropod allergies |
| 03/14/2002 | CA2730627A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2431711A1 Remedies for heart failure |
| 03/14/2002 | CA2422506A1 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 03/14/2002 | CA2422114A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | CA2421912A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2421911A1 Monocot seeds with increased lignan content |
| 03/14/2002 | CA2421872A1 Mechanism of mitochondrial membrane permeabilization by hiv-1 vpr, mimetics of vpr and methods of screening active molecules having the ability to alter and/or prevent and/or mimic the interaction of vpr with ant |
| 03/14/2002 | CA2421842A1 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 03/14/2002 | CA2421840A1 Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them |
| 03/14/2002 | CA2421783A1 Receptor in the edb fibronectin domain |
| 03/14/2002 | CA2421760A1 G-csf analog compositions and methods |
| 03/14/2002 | CA2421757A1 G-csf analog compositions and methods |
| 03/14/2002 | CA2421723A1 Stat3 agonists and antagonists and therapeutic uses thereof |
| 03/14/2002 | CA2421448A1 Hla binding peptides and their uses |
| 03/14/2002 | CA2421445A1 Hla binding peptides and their uses |
| 03/14/2002 | CA2421409A1 Use of lipopeptides for immunotherapy of hiv-positive subjects |
| 03/14/2002 | CA2421386A1 Disease-resistant plants and method of constructing the same |
| 03/14/2002 | CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | CA2421374A1 Methods and compositions for diseases associated with amyloidosis |
| 03/14/2002 | CA2421324A1 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421251A1 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| 03/14/2002 | CA2421248A1 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 03/14/2002 | CA2421218A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | CA2421199A1 Hiv regulatory and auxiliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | CA2421193A1 Hiv peptides, antigens, vaccine compositions,immunoassay kit and a method of detecting antibodies induced by hiv |
| 03/14/2002 | CA2421191A1 Methods and compositions for in vitro targeting |